These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Wearing-off detection in clinical practice: the wearing off real practice key (WORK-PD) study in Parkinson's disease. Altavista MC, Cassetta E, Brusa L, Viselli F, Denaro A, Ventriglia M, Pasqualetti P, Peppe A. Parkinsonism Relat Disord; 2015 Feb; 21(2):95-100. PubMed ID: 25443558 [Abstract] [Full Text] [Related]
7. Wearing off: A complex phenomenon often poorly recognized in Parkinson's disease. A study with the WOQ-19 questionnaire. Pistacchi M, Gioulis M, Sanson F, Marsala SZ. Neurol India; 2017 Feb; 65(6):1271-1279. PubMed ID: 29133700 [Abstract] [Full Text] [Related]
10. [Patients' perspective on Parkinson disease therapies: results of a large-scale survey in Japan]. Fujimoto K, Murata M, Hattori N, Kondo T. Brain Nerve; 2011 Mar; 63(3):255-65. PubMed ID: 21386127 [Abstract] [Full Text] [Related]
12. Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. Abbruzzese G, Antonini A, Barone P, Stocchi F, Tamburini T, Bernardi L, Amboni M, Vacca L, Posocco V, Colombo D. Neurol Sci; 2012 Dec; 33(6):1319-27. PubMed ID: 22307444 [Abstract] [Full Text] [Related]
15. The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter Study. Ouma S, Fukae J, Fujioka S, Yamamoto S, Hatano T, Yoritaka A, Okuma Y, Kashihara KI, Hattori N, Tsuboi Y. Intern Med; 2017 Dec; 56(15):1961-1966. PubMed ID: 28768964 [Abstract] [Full Text] [Related]
17. The wearing-off phenomenon and the use of questionnaires to facilitate its recognition in Parkinson's disease. Stacy M. J Neural Transm (Vienna); 2010 Jul; 117(7):837-46. PubMed ID: 20563826 [Abstract] [Full Text] [Related]
18. Optimizing long-term therapy for Parkinson disease: levodopa, dopamine agonists, and treatment-associated dyskinesia. Stacy M, Galbreath A. Clin Neuropharmacol; 2008 Jul; 31(1):51-6. PubMed ID: 18303491 [Abstract] [Full Text] [Related]
19. Optimizing pharmacotherapy: strategies to manage the wearing-off phenomenon. Tse W. J Am Med Dir Assoc; 2006 Sep; 7(7 Suppl 2):12-7. PubMed ID: 17948614 [Abstract] [Full Text] [Related]